Mesa Laboratories Stock Performance
| MLAB Stock | USD 70.05 5.08 6.76% |
The company secures a Beta (Market Risk) of 1.84, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesa Laboratories will likely underperform. At this point, Mesa Laboratories has a negative expected return of -0.65%. Please make sure to verify Mesa Laboratories' daily balance of power, market facilitation index, and the relationship between the kurtosis and day median price , to decide if Mesa Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Mesa Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (6.76) | Five Day Return (18.20) | Year To Date Return (46.92) | Ten Year Return (26.84) | All Time Return 2.2 K |
Forward Dividend Yield 0.0068 | Payout Ratio | Forward Dividend Rate 0.64 | Dividend Date 2025-09-15 | Ex Dividend Date 2025-05-30 |
1 | Acquisition by Tripeny R Tony of 1105 shares of Mesa Laboratories subject to Rule 16b-3 | 05/05/2025 |
2 | Sensus Healthcare, Inc. Reports Q1 Loss, Tops Revenue Estimates | 05/15/2025 |
3 | Disposition of 386 shares by Brian Archbold of Mesa Laboratories at 133.69 subject to Rule 16b-3 | 05/23/2025 |
4 | Mesa Laboratories Full Year 2025 Earnings EPS Misses Expectations | 05/30/2025 |
5 | Trend Tracker for - news.stocktradersdaily.com | 06/03/2025 |
6 | Disposition of 99 shares by Gary Owens of Mesa Laboratories at 203.54 subject to Rule 16b-3 | 06/10/2025 |
7 | Disposition of 793 shares by John Sakys of Mesa Laboratories subject to Rule 16b-3 | 06/13/2025 |
| Mesa Laboratories dividend paid on 16th of June 2025 | 06/16/2025 |
8 | Disposition of 2840 shares by John Sakys of Mesa Laboratories subject to Rule 16b-3 | 06/18/2025 |
9 | Disposition of 3301 shares by Gary Owens of Mesa Laboratories subject to Rule 16b-3 | 06/20/2025 |
10 | Mesa Laboratories, Inc. dropped from Russell 2000 Value-Defensive Index - MarketScreener | 06/30/2025 |
11 | Mesa Laboratories declares 0.16 dividend | 07/03/2025 |
12 | Mesa Laboratories, Inc.s Intrinsic Value Is Potentially 32 percent Above Its Share Price | 07/07/2025 |
13 | Mesa Laboratories Inc Stock Price Down 7.59 percent on Jul 18 | 07/18/2025 |
| Begin Period Cash Flow | 28.2 M | |
| Total Cashflows From Investing Activities | -4.5 M |
Mesa Laboratories Relative Risk vs. Return Landscape
If you would invest 10,885 in Mesa Laboratories on April 21, 2025 and sell it today you would lose (3,880) from holding Mesa Laboratories or give up 35.65% of portfolio value over 90 days. Mesa Laboratories is currently does not generate positive expected returns and assumes 3.1392% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Mesa, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mesa Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesa Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mesa Laboratories, and traders can use it to determine the average amount a Mesa Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2063
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MLAB |
Estimated Market Risk
| 3.14 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.65 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mesa Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mesa Laboratories by adding Mesa Laboratories to a well-diversified portfolio.
Mesa Laboratories Fundamentals Growth
Mesa Stock prices reflect investors' perceptions of the future prospects and financial health of Mesa Laboratories, and Mesa Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mesa Stock performance.
| Return On Equity | -0.0129 | ||||
| Return On Asset | 0.025 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 580.9 M | ||||
| Shares Outstanding | 5.5 M | ||||
| Price To Earning | 433.94 X | ||||
| Price To Book | 2.67 X | ||||
| Price To Sales | 1.60 X | ||||
| Revenue | 240.98 M | ||||
| Gross Profit | 152.1 M | ||||
| EBITDA | 42.35 M | ||||
| Net Income | (1.97 M) | ||||
| Cash And Equivalents | 43.75 M | ||||
| Cash Per Share | 8.23 X | ||||
| Total Debt | 181.47 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.90 X | ||||
| Book Value Per Share | 29.30 X | ||||
| Cash Flow From Operations | 46.81 M | ||||
| Earnings Per Share | (0.36) X | ||||
| Market Capitalization | 385.38 M | ||||
| Total Asset | 433.35 M | ||||
| Retained Earnings | (188.94 M) | ||||
| Working Capital | (61.28 M) | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 657 K | ||||
About Mesa Laboratories Performance
By analyzing Mesa Laboratories' fundamental ratios, stakeholders can gain valuable insights into Mesa Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mesa Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mesa Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 102.75 | 97.61 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Mesa Laboratories performance evaluation
Checking the ongoing alerts about Mesa Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mesa Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mesa Laboratories generated a negative expected return over the last 90 days | |
| Mesa Laboratories has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 152.1 M. | |
| Over 96.0% of the company shares are owned by institutional investors | |
| On 16th of June 2025 Mesa Laboratories paid $ 0.16 per share dividend to its current shareholders | |
| Latest headline from gurufocus.com: Mesa Laboratories Inc Stock Price Down 7.59 percent on Jul 18 |
- Analyzing Mesa Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mesa Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Mesa Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mesa Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mesa Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mesa Laboratories' stock. These opinions can provide insight into Mesa Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |